Semnur Pharmaceuticals, Inc.
What this means
- Stockholders’ deficitAt the end of 2025 total liabilities exceeded total assets: stockholders’ equity was −$20.8M (XBRL data filed with the SEC).
- Net loss in 2025Net loss of $160M for the year (2024: −$4.7M).
What to do next
- NT 10-K: what a late-filing notice actually meansguide
- How to check a US company before you sign a contractguide
- How to read an 8-K: what customers and creditors should checkguide
Guides from the Companies Daily newsroom, picked for what the register shows.
Financials from XBRL
| Calendar-year frame | 2025 | 2024 |
|---|---|---|
| Net income (loss) | −$160M | −$4.7M |
| Total assets | $1.3M | $6.7M |
| Total liabilities | $22.1M | $49.5M |
| Stockholders’ equity | −$20.8M | −$42.8M |
| Cash and equivalents | $20K | $12K |
From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.
- Name as filed
- Semnur Pharmaceuticals, Inc.
Formerly: Denali Capital Acquisition Corp. - CIK
- 0001913577
- Tickers
- SMNR, SMNRW
- Kind of filer
- SEC-reporting company
Non-accelerated filer; Smaller reporting company; Emerging growth company - Status
- Filing with the SEC
- State of incorporation
- Delaware
- Business address
- Palo Alto, California
- Industry (SIC)
- 2834 · Pharmaceutical preparations
Industry: D · Manufacturing → - Fiscal year ends
- December 31
- Last annual report
- 10-K for the period ended Dec 31, 2025
- Last quarterly report
- 10-Q for the quarter ended Sep 30, 2026
- Bankruptcy reported
- Not in our data
- Last edition event
- Nov 4, 2026
Filing history
Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.
- Form 10-Q · filed Nov 4, 2026 · filing · edition of Nov 4, 2026
- Form 10-Q · filed Aug 10, 2026 · filing
- Form 10-Q · filed May 13, 2026 · filing
- Form 8-K · items 5.02, 9.01 · filed Mar 17, 2026 · filing
- Form 10-K · filed Feb 27, 2026 · filing
- Form 10-Q · filed Nov 12, 2025 · filing
- Form S-1 · filed Oct 21, 2025 · filing
- Form 8-K · items 1.01, 2.01, 2.03, 3.02, 3.03, 4.01, 5.01, 5.02, 5.03, 5.05, 5.06, 7.01, 8.01 · filed Sep 26, 2025 · filing
- Form 8-K · items 1.01, 2.01, 2.03, 3.02, 3.03, 4.01, 5.01, 5.02, 5.03, 5.05, 5.06, 7.01, 8.01 · filed Sep 26, 2025 · filing
- Form 8-K · items 1.01, 2.01, 2.03, 3.02, 3.03, 4.01, 5.01, 5.02, 5.03, 5.05, 5.06, 7.01, 8.01 · filed Sep 26, 2025 · filing
- Form 8-K · items 1.01, 2.01, 2.03, 3.02, 3.03, 4.01, 5.01, 5.02, 5.03, 5.05, 5.06, 7.01, 8.01 · filed Sep 26, 2025 · filing
- Form 10-Q · filed Aug 15, 2025 · filing
- Form NT 10-Q · filed Aug 14, 2025 · filing
- Form 25-NSE · filed Jul 14, 2025 · filing
- Form 10-Q · filed May 16, 2025 · filing
- Form NT 10-Q · filed May 15, 2025 · filing
- Form 8-K · items 3.01 · filed Apr 9, 2025 · filing
- Form 10-K · filed Apr 2, 2025 · filing
- Form NT 10-K · filed Apr 1, 2025 · filing
- Form 10-Q · filed Nov 19, 2024 · filing
- Form NT 10-Q · filed Nov 14, 2024 · filing
- Form 8-K · items 3.01 · filed Oct 7, 2024 · filing
- Form SC 13D · filed Sep 9, 2024 · filing
- Form 10-Q · filed Aug 19, 2024 · filing
- Form NT 10-Q · filed Aug 14, 2024 · filing
- Form 8-K · items 4.01, 9.01 · filed Jul 17, 2024 · filing
- Form 10-Q · filed May 22, 2024 · filing
- Form NT 10-Q · filed May 15, 2024 · filing
- Form 10-K · filed Apr 1, 2024 · filing
- Form 8-K · items 3.01, 9.01 · filed Feb 27, 2024 · filing
- Form 10-Q · filed Nov 9, 2023 · filing
- Form 10-Q · filed Aug 15, 2023 · filing
- Form NT 10-Q · filed Aug 14, 2023 · filing
- Form 10-Q · filed May 15, 2023 · filing
- Form 10-K · filed Mar 17, 2023 · filing